INTRODUCTION: The annual economic burden of treating cancer to the National Health
Service (NHS) in the United Kingdom (UK) is over£ 15 billion; and for non small cell lung …

Objectives Considering quality of life in oncology is particularly important, given that
extension of life provided by treatments are often associated with large disutilities. There are …

Objectives The aim of this study was to develop and validate mapping algorithms to predict
EQ-5D-5L utilities from two questionnaires (Functional Assessment of Anorexia/Cachexia …

Objectives Mapping a disease specific measure of quality of life to a generic instrument is
one available technique to obtain utility values for cost-effectiveness studies. Based on a …

Background. Clinical trials in cancer frequently include cancer-specific measures of health
but not preference-based measures such as the EQ-5D that are suitable for economic …

Many clinical trials involve parallel collection of quality of life (QoL) and economic data,
requiring patients to complete similar questionnaires at regular intervals. This additional …

Abstract Background Although cancer-specific Health-Related Quality of Life (HRQOL) are
commonly included in randomized clinical trials or other prospective non-randomized …

The EQ-5D-3L is a tool that is used for the measurement and valuation of the health of
populations for research. It is a self-reported questionnaire, with five questions and …

Background Several mapping or cross-walking algorithms for deriving utilities from the
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire …

Introduction: Cost-effectiveness analyses often inform healthcare reimbursement decisions.
The preferred measure of effectiveness is the quality adjusted life year (QALY) gained …